Sharron

Sharon Bio-Medicine is an Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), finished dosage forms, and intermediates. The company operates across several therapeutic segments, including cardiovascular, central nervous system, and anti-infectives, providing both generic formulations and contract manufacturing services. Sharon Bio-Medicine maintains manufacturing facilities that have historically received approvals from international regulatory bodies such as the US FDA and UK MHRA. Following a period of financial distress and insolvency proceedings under the National Company Law Tribunal (NCLT), the company was acquired and is currently undergoing a revival under new management. Its business model focuses on the global supply of high-quality affordable medicines and specialized chemical intermediates.